Cysteine engineered antibodies and conjugates

Details for Australian Patent Application No. 2005286607 (hide)

Owner Genentech, Inc.

Inventors Eigenbrot, Charles W.; Raab, Helga E.; Junutula, Jagath Reddy; Vandlen, Richard; Lowman, Henry

Agent Griffith Hack

Pub. Number AU-B-2005286607

PCT Pub. Number WO2006/034488

Priority 60/696,353 30.06.05 US; 60/612,468 23.09.04 US

Filing date 22 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 27 January 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/034488 Priority application(s): WO2006/034488

27 January 2011 Application Accepted

  Published as AU-B-2005286607

26 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286608-C-aryl glucoside SGLT2 inhibitors and method for their production

2005286593-Novel pyridine compounds, process for their preparation and compositions containing them